Study is the first to identify discrete genetic mutations associated with smoking, to establish a dose-response relationship between smoking and genetic mutations and to show that continuing to smoke leads to more mutations and worse MDS
Phase 2 trial finds durvalumab–ceralasertib boosted immune response and improved outcomes in patients with lung cancer
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.